home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Relay Therapeutics, Inc. - Common Stock (NQ:RLAY)

8.770 -0.380 (-4.15%)

Streaming Delayed Price Updated: 2:43 PM EST, Feb 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Relay Therapeutics, Inc. - Common Stock

Evogene Offers An Excellent Risk/Reward Ratio ↗

March 21, 2023

We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their...

Via Talk Markets

Relay Therapeutics to Present Initial Clinical Data on RLY-2608 at AACR

March 06, 2023

Relay Therapeutics to host conference call following AACR presentation

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics's Return On Capital Employed Overview ↗

March 01, 2023

Via Benzinga

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

March 01, 2023

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics Earnings Preview ↗

February 22, 2023

Via Benzinga

5 Analysts Have This to Say About Relay Therapeutics ↗

September 30, 2022

Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings within the last quarter:

Via Benzinga

Expert Ratings for Relay Therapeutics ↗

September 30, 2022

Within the last quarter, Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings:

Via Benzinga

Relay Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

February 23, 2023

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

February 16, 2023

From Relay Therapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 ↗

February 03, 2023

Via Benzinga

4 Analysts Have This to Say About Relay Therapeutics ↗

September 14, 2022

Within the last quarter, Relay Therapeutics (NASDAQ:RLAY) has observed the following analyst ratings:

Via Benzinga

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day

February 02, 2023

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference

January 03, 2023

From Relay Therapeutics, Inc.

Via GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

November 07, 2022

From Relay Therapeutics, Inc.

Via GlobeNewswire

Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session ↗

December 19, 2022

Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial.

Via Benzinga

Relay Therapeutics Reports Third Quarter 2022 Financial Results and Corporate Highlights

November 03, 2022

From Relay Therapeutics, Inc.

Via GlobeNewswire

Earnings Scheduled For November 3, 2022 ↗

November 03, 2022

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

Via Benzinga

Relay Therapeutics's Earnings Outlook ↗

November 02, 2022

Relay Therapeutics (NASDAQ:RLAY) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Relay...

Via Benzinga

Relay Therapeutics to Announce Third Quarter 2022 Financial Results and Corporate Highlights

October 27, 2022

From Relay Therapeutics, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For September 30, 2022 ↗

September 30, 2022

Upgrades

Via Benzinga

7 Unknown Biotech Stocks That Could Rocket in 2023 ↗

September 23, 2022

Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.

Via InvestorPlace

Wells Fargo Slashes Price Target On This Stock By Over 71%, Also Check Out Other Major PT Changes Here ↗

September 14, 2022

Wells Fargo cut the price target on Cabaletta Bio, Inc. (NASDAQ: CABA) from $14 to $4. Wells Fargo analyst Derek Archila maintained the stock with an Overweight rating. Cabaletta Bio shares gained 0.9%...

Via Benzinga

Tesla, Meta, NVIDIA And Other Big Losers From Tuesday ↗

September 14, 2022

U.S. stocks closed sharply lower with the Nasdaq Composite dipping more than 5% on Tuesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

September 13, 2022

Via Benzinga

Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday ↗

September 14, 2022

Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX...

Via Benzinga

Why Relay Therapeutics Shares Are Getting Hammered ↗

September 13, 2022

Relay Therapeutics Inc (NASDAQ: RLAY) shares are trading lower by 11.33% to $25.54 Tuesday morning after the company priced a roughly 11.32 million share public offering of common stock at $26.50 per...

Via Benzinga

Why Amazon, Microsoft, Apple Shares Are Trading Lower, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session ↗

September 13, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 186% to $47.69 as the stock started trading on a 1-for-30 reverse split basis.

Via Benzinga

Relay Therapeutics, Rent the Runway And Some Other Big Stocks Moving Lower In Today's Pre-Market Session ↗

September 13, 2022

U.S. stock futures traded higher this morning ahead of the much-awaited inflation data for August. Here are some big stocks moving lower in today’s pre-market trading session.

Via Benzinga

Why SeaChange International Is Trading Higher By Around 15%; Here Are 26 Stocks Moving Premarket ↗

September 13, 2022

Gainers Comera Life Sciences Holdings, Inc. (NASDAQ: CMRA) rose 41.7% to $2.72 in pre-market trading. Comera Life Sciences Form 4 filing showed multiple insiders purchased 122,600 shares at an average...

Via Benzinga

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com